HomeScients and PhysiciansPatients and Families

Back    Protocols for Newborn Screening Result    CPT1 Protocol

Carnitine palmitoyltransferase I (CPT I deficiency) is an enzyme that catalyzes the binding of fatty acids to carnitine, forming the fatty acylcarnitines that allow the transport of fatty acids into mitochondria where they are oxidized and thus utilized for energy. In CPT I deficiency the lack of binding to carnitine excludes the fatty acids from the mitochondria. Consequently there is decreased tolerance for fasting or any hypoglycemia state wherein energy must be supplied from fats. Death during a metabolic crisis can ensue.

History and examination
The infant and parent(s) must be seen within the next day or two following notification from the newborn screening laboratory. A METABOLIC PHYSICIAN MUST BE CONSULTED.

History
For CPT I deficiency the infant may have a normal history. On occasion however, there is a history of neonatal lethargy, acute liver failure, seizures or coma. Since both these conditions are autosomal recessive genetic disorders, there is a 25% chance that sibs of the identified infant may also have CPT I deficiency. A family history of siblings or other children becoming seriously ill particularly with liver failure or sudden death is very significant as is a history of the childŐs mother having the HELLP syndrome during pregnancy ( hemolysis, elevated liver enzymes and low platelets) or acute fatty liver of pregnancy (AFLP).

Examination
The infant may be entirely well. Neonatal signs include seizures, hepatomegaly and, rarely, arrhythmias and mild cardiomegaly. Laboratory findings during neonatal illness include hypoglycemia, metabolic acidosis, hyperammonemia, elevated CK and markedly increased carnitine. ANY signs of illness must be treated as a medical emergency and treated immediately by a metabolic physician.
If the child appears well it is still essential to refer to the metabolic center to ensure that the child and family receive the necessary treatment and guidance to prevent any morbidity.
Contact metabolic physician for markedly elevated carnitine profile

ENSURE THAT THE REPEAT NEWBORN SCREENING SAMPLE IS SENT TO THE STATE LABORATORY AND THE RESULT OBTAINED ASAP
(Go to NNSGRC for the state labs)

Discussion with parents for markedly elevated carnitine profile

 

Instructions
Results: